Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Strong start to the week
Mon, 15 Jun Closing

Indian markets continued to trade in the green during the last hours of trade. The Sensex ended higher by 161 points or 0.6%, while the NSE-Nifty closed higher by 31 points or 0.4%. Sectoral indices closed the day on a mixed note with Pharma and Auto stocks leading the gains. The BSE Mid Cap index is trading marginally down, while the BSE Small Cap index is trading up by 0.4%.

At the time of writing, the INR was trading at 64.08 to the US dollar. Stocks in Europe were trading in the red at the time of writing.

Automobile stocks closed their session on a mixed note with Eicher Motors and Bajaj Auto leading the gains. As per a leading financial daily, Ashok Leyland, the Hinduja group flagship company in India, is seeking shareholders approval to raise money through Qualified Institutional buyers (QIBs) and other routes. This proposed fund raising is for supporting the company's capex, working capital and investment in joint ventures and other purposes. Meanwhile, the management of the company has reportedly stated that it has lined up capex and investment to the tune of around Rs 2.5 to 3 bn during the current fiscal. Stock of Ashok Leyland is trading down nearly 0.8%.

Stocks in the pharma sector have closed on a mixed note with Elder Pharma and Sun Pharma witnessing buying interest. Shares of Glenmark Pharmaceuticals surged almost 2% today after the company announced that it has been granted final approval by the United States Food & Drug Administration (USFDA) for oral contraceptive tablets. This approval is for the AB-rated generic version of Seasonale by Teva Women's Health. This approval marks Glenmark's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorized for distribution by the USFDA. This is a positive for the company especially considering the fact that its sales from the US were impacted in FY15 on account of delays in drug approvals.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Strong start to the week". Click here!

  

Views on News

The Best Stocks in a Volatile Market podcast (Views On News)

Mar 5, 2021

Rahul Shah on the qualities that make for a good investment in an up and down market.

A New Super Cycle in Metals? (Fast Profits Daily)

Mar 5, 2021

In this video, I'll tell you if there is huge money to be made in metals or if there is more to the super cycle story.

Mirae Asset Corporate Bond Fund: Aiming for Growth with Focus on Quality and Liquidity (Outside View)

Mar 5, 2021

PersonalFN analyses the features of Mirae Asset Corporate Bond Fund and explains the potential this fund has to offer to its investors.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution (Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Inflation & Your Investments (Fast Profits Daily)

Mar 4, 2021

Inflation is the buzz word in the world of finance these days. It impacts all of us. Here's how it affects your investments.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Mar 5, 2021 (Close)

MARKET STATS